How do Payers utilize the AMCP eDossier System for pre-approval information and could it qualify as a safe harbor?

Webinar Recorded on January 18, 2017 

 Click here to download PDF of presentation


Currently there is no accepted FDA sanctioned safe harbor mechanism for the exchange of truthful and non-misleading information between payers and manufacturers and the FDA is currently reviewing options. Payers are reviewing products in many cases 18-24 months in advance of FDA approval to meet budget and formulary approval timelines. The AMCP eDossier System (System) has been supporting the exchange of manufacturer-provided approved dossier information since 2009. The need for pre-approval information is apparent, as indicated during the recent FDA hearings. This webinar will review research and evidence that can support the opportunity to use the AMCP eDossier System as a potential safe harbor mechanism.

Specifically this webinar will review:

  • Recent research on how US payers are utilizing the AMCP eDossier System for pre-approval information
  • eDossier insights regarding the information exchange, tracking and usage
  • Discuss how this System could be a potential safe harbor mechanism for pre-approval information and support the decision making process
  • Payer perspective on the need for pre-approval information for HDCM budget and formulary planning


  • Jackie Gladman, Vice President, Sales and Marketing, Dymaxium
  • Elizabeth Sampsel, PharmD, MBA, Senior Payer Consultant, Dymaxium
  • Alan Pannier, PharmD, MBA, Director of Clinical Services, Veridicus Health